To gain further insights on how to fully exploit the therapeutic potential of melatonin in advanced prostate cancer and CRPC management, the present study was conducted to investigate any functional interactions among AR-V7, NF-κB, and melatonin in human prostate cancer cells. Here, NFKB1 is linked to Familial prostate cancer.